ArticleRespiratory research2020

CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma.

Claire Emson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.